Colistimethate sodium and tobramycin dry powders for inhalation for treating pseudomonas lung infection in cystic fibrosis

  • Technology appraisal guidance
  • TA276
  • Published: 

Evidence

Documents containing the evidence that was used to develop the recommendations.

Supporting evidence